Glenview Trust co Boosts Position in UnitedHealth Group Incorporated $UNH

Glenview Trust co increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 51,836 shares of the healthcare conglomerate’s stock after acquiring an additional 2,264 shares during the quarter. Glenview Trust co’s holdings in UnitedHealth Group were worth $27,149,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP increased its position in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the period. GAMMA Investing LLC increased its position in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the period. Finally, Bank of New York Mellon Corp increased its position in UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after buying an additional 196,696 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 8.8%

UNH opened at $348.59 on Wednesday. The business’s fifty day moving average is $289.41 and its two-hundred day moving average is $371.39. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market cap of $315.71 billion, a price-to-earnings ratio of 15.10, a PEG ratio of 2.09 and a beta of 0.45. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on UNH shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Barclays boosted their target price on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Morgan Stanley dropped their target price on UnitedHealth Group from $342.00 to $325.00 and set an “overweight” rating on the stock in a report on Wednesday, August 20th. Finally, Bank of America upped their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $355.77.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.